Infection control business Nanosonics posted disappointing half year numbers today with revenue falling 11% on 1H20. There was a marked fall in installments made in the final quarter of last financial year which continued into the first half, though the company noted a rebound into the 2nd quarter.
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required